Cargando…
Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778550/ https://www.ncbi.nlm.nih.gov/pubmed/31321747 http://dx.doi.org/10.1007/s13300-019-0670-y |
| _version_ | 1783456779509694464 |
|---|---|
| author | Ali, Amar Bain, Steve Hicks, Debbie Newland Jones, Phillip Patel, Dipesh C. Evans, Marc Fernando, Kevin James, June Milne, Nicola Viljoen, Adie Wilding, John |
| author_facet | Ali, Amar Bain, Steve Hicks, Debbie Newland Jones, Phillip Patel, Dipesh C. Evans, Marc Fernando, Kevin James, June Milne, Nicola Viljoen, Adie Wilding, John |
| author_sort | Ali, Amar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6778550 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67785502019-10-17 Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice Ali, Amar Bain, Steve Hicks, Debbie Newland Jones, Phillip Patel, Dipesh C. Evans, Marc Fernando, Kevin James, June Milne, Nicola Viljoen, Adie Wilding, John Diabetes Ther Correction Springer Healthcare 2019-07-18 2019-10 /pmc/articles/PMC6778550/ /pubmed/31321747 http://dx.doi.org/10.1007/s13300-019-0670-y Text en © The Author(s) 2019 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Correction Ali, Amar Bain, Steve Hicks, Debbie Newland Jones, Phillip Patel, Dipesh C. Evans, Marc Fernando, Kevin James, June Milne, Nicola Viljoen, Adie Wilding, John Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice |
| title | Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice |
| title_full | Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice |
| title_fullStr | Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice |
| title_full_unstemmed | Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice |
| title_short | Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice |
| title_sort | correction to: sglt2 inhibitors: cardiovascular benefits beyond hba1c—translating evidence into practice |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778550/ https://www.ncbi.nlm.nih.gov/pubmed/31321747 http://dx.doi.org/10.1007/s13300-019-0670-y |
| work_keys_str_mv | AT aliamar correctiontosglt2inhibitorscardiovascularbenefitsbeyondhba1ctranslatingevidenceintopractice AT bainsteve correctiontosglt2inhibitorscardiovascularbenefitsbeyondhba1ctranslatingevidenceintopractice AT hicksdebbie correctiontosglt2inhibitorscardiovascularbenefitsbeyondhba1ctranslatingevidenceintopractice AT newlandjonesphillip correctiontosglt2inhibitorscardiovascularbenefitsbeyondhba1ctranslatingevidenceintopractice AT pateldipeshc correctiontosglt2inhibitorscardiovascularbenefitsbeyondhba1ctranslatingevidenceintopractice AT evansmarc correctiontosglt2inhibitorscardiovascularbenefitsbeyondhba1ctranslatingevidenceintopractice AT fernandokevin correctiontosglt2inhibitorscardiovascularbenefitsbeyondhba1ctranslatingevidenceintopractice AT jamesjune correctiontosglt2inhibitorscardiovascularbenefitsbeyondhba1ctranslatingevidenceintopractice AT milnenicola correctiontosglt2inhibitorscardiovascularbenefitsbeyondhba1ctranslatingevidenceintopractice AT viljoenadie correctiontosglt2inhibitorscardiovascularbenefitsbeyondhba1ctranslatingevidenceintopractice AT wildingjohn correctiontosglt2inhibitorscardiovascularbenefitsbeyondhba1ctranslatingevidenceintopractice AT correctiontosglt2inhibitorscardiovascularbenefitsbeyondhba1ctranslatingevidenceintopractice |